1260180004: Growing teratoma syndrome (disorder)

• SNOMED CT Concept\Clinical finding (finding)\...
• \Procedure related finding\Complication of chemotherapy (disorder)\Growing teratoma syndrome
• \Procedure related finding\Disorder following clinical procedure\Growing teratoma syndrome
• \Disease\Complication of chemotherapy (disorder)\Growing teratoma syndrome
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Germ cell tumor (disorder)\Teratoma (disorder)\Growing teratoma syndrome
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Benign neoplastic disease\Growing teratoma syndrome
• \Disease\Disorder following clinical procedure\Growing teratoma syndrome

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
5159596015	Growing teratoma syndrome	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5159597012	Growing teratoma syndrome (disorder)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5159598019	A rare neoplastic disorder characterised by benign metastatic masses increasing in size and number after chemotherapy for non-seminomatous germ cell tumours of testis or ovary. It may present at any time after chemotherapy, with a median occurrence within 24 months after treatment completion. Per definition, the resected specimen exclusively contains mature teratoma components, and serum tumour markers have normalised. The retroperitoneum is the most common site, although almost any other localisation has been reported. Increased tumour size may cause mechanical compression of vital organs, with renal dysfunction, bowel ischaemia and biliary obstruction as major complications.	en	Definition	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
5159599010	A rare neoplastic disorder characterized by benign metastatic masses increasing in size and number after chemotherapy for non-seminomatous germ cell tumors of testis or ovary. It may present at any time after chemotherapy, with a median occurrence within 24 months after treatment completion. Per definition, the resected specimen exclusively contains mature teratoma components, and serum tumor markers have normalized. The retroperitoneum is the most common site, although almost any other localization has been reported. Increased tumor size may cause mechanical compression of vital organs, with renal dysfunction, bowel ischemia and biliary obstruction as major complications.	en	Definition	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start